XML Print


1- Member of AIMS Australia, and, Consultant Clinical Immunology, Padtan Danesh Company, Tehran, Iran , mohammad_esfahan@yahoo.com
2- MBBS, General Practitioner, Australia
3- Technical Officer, Padtan Danesh Company, Tehran, Iran
4- CEO, Padtan Danesh Company, Tehran, Iran
5- Doctorate of laboratory medicine, Vahid Laboratory Director, Isfahan, Iran
Abstract:   (508 Views)
Anti-centromere antibodies (ACA) are most commonly identified by indirect immunofluorescence (IIF) on HEp-2 cells, where they usually produce the characteristic centromere pattern (AC-3) associated with limited cutaneous systemic sclerosis. With the increasing routine use of solid-phase assays such as ELISA, situations arise in which assay results do not fully align. We report the case of a 75-year-old woman with features suggestive of systemic autoimmune disease whose ANA testing by IIF demonstrated a multiple nuclear dots pattern (AC-6) with elements resembling a CENP-F–like pattern (AC-14), rather than the classic centromere pattern. In contrast, solid-phase testing detected anti-centromere reactivity. This case illustrates how pattern recognition on IIF and antigen-specific assays may diverge and underscores the importance of interpreting serologic results within clinical context and across complementary laboratory platforms.
 
Full-Text [PDF 513 kb]   (175 Downloads)    
Research Article: Case Report | Subject: Immunology
Received: 2026/01/2 | Accepted: 2026/06/6

References
1. Mahler M, You D, Baron M, Taillefer SS, Hudson M, Canadian Scleroderma Research Group(CSRG) Fritzler MJ, et al. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta. 2011;412(2122):1937-43. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol. 2005;32(8):1488-94. [View at Publisher] [PMID] [Google Scholar]
3. Zhao Y, et al. Correlation among different anti-centromere assays and HEp-2 IIF patterns. Clin Chim Acta. 2018;481:39-46.
4. Fritzler MJ, Chan EKL. Clinical relevance of HEp-2 IIF patterns including rare patterns. Autoimmun Rev. 2015;14:967-974.
5. International Consensus on ANA Patterns (ICAP). AC-14 CENP-F-like pattern. Available from: https://www.anapatterns.org/view_pattern.php?pattern=14 [Accessed 2026 May 29].
6. Hur K, Jearn LH, Kim TY. Centromere protein-F-like pattern in a patient with rheumatoid arthritis. Ann Lab Med. 2019;39(2):227-228. [DOI] [PMID] [Google Scholar]
7. Sheikh Sajjadieh M, Ajami A, Haghshenas L. Estimation of sensitivity and specificity of antinuclear antibody by automated indirect immunofluorescence and enzyme-linked immunoassay. mljgoums. 2024;18(4):22-3.
8. Mahler M, Fritzler MJ. The clinical significance of the anti-centromere antibody assay in systemic autoimmune rheumatic diseases. Autoimmun Rev. 2021;20(8):102912.
9. Infantino M, Meacci F, Grossi V, et al. The burden of discordant anti-nuclear antibody testing in clinical practice. Diagnostics (Basel). 2022;12(5):1148.
10. Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA Patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879-89. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Chan EKL, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PLC, et al. Report of the first International Consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015. Front Immunol. 2015;6:412 [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.